VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding VivoSim Labs, INC. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 63.7K | 128.6K | +64.9K (+101.9%) |
| Value | $142.6K | $189.0K | +$46.4K (+32.5%) |
New holders (8)
Institutions that held VivoSim Labs, INC. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 57,493 | $84.5K | 0.00% |
| Susquehanna International Group, LLP | 16,727 | $24.6K | 0.00% |
| Raymond James Financial Inc | 3,313 | $4.87K | 0.00% |
| Farther Finance Advisors, LLC | 58 | $85 | 0.00% |
| FMR LLC | 10 | $15 | 0.00% |
| Total Investment Management Inc | 2 | $3 | 0.00% |
| Koesten, Hirschmann & Crabtree, INC. | 2 | $3 | 0.00% |
| Citigroup Inc | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held VivoSim Labs, INC. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Prescott Group Capital Management, L.L.C. | 23,375 | $52.4K |
| Danske Bank A/S | 4 | $9 |
| Cullen/Frost Bankers, Inc. | 2 | $4 |
| CIBC Private Wealth Group, LLC | 1 | $2 |
| CWM, LLC | 6 | $0 |